Provides a rational approach to the management of patients presenting with temperature and rigidity to reduce incidence, recognize early, and treat neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
May inform initial management of suspected neuroleptic malignant syndrome; leaves open the need for prospective validation.
The neuroleptic malignant syndrome is a rare, potentially fatal, adverse reaction to neuroleptic drugs characterised by severe rigidity, high temperature and autonomic dysfunction. In the light of the hypothesized pathophysiology of this condition, a rational approach to the management of patients presenting with temperature and rigidity is provided. The aims of this approach are three-fold: to reduce the incidence of the condition, to be able to recognise it early so as to treat before life-threatening complications arise, and to be able to recognise early those conditions which mimic neuroleptic malignant syndrome, so as not to delay their specific treatment.
No takes yet. Share an insight, caveat, or question.
Martin Balzan (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: